VCYT
Closed
Veracyte Inc
28.57
-1.20 (-4.03%)
Last Update: 06 Sep 2024 23:00:00
Yesterday: 29.77
Day's Range: 28.44 - 29.79
Send
sign up or login to leave a comment!
When Written:
21.39
Veracyte Inc. is a genomic diagnostics company that uses advanced genomic technology to provide diagnostic solutions for patients with thyroid and lung diseases. The company's products and services are designed to help physicians make more informed treatment decisions by providing accurate and actionable information about a patient's disease. Veracyte's genomic tests are based on the analysis of RNA sequencing data and are designed to identify gene expression patterns that are characteristic of specific diseases. The company's flagship product is the Afirma Thyroid FNA Analysis, which is used to diagnose thyroid nodules and reduce unnecessary surgeries. Veracyte is headquartered in South San Francisco, California and was founded in 2008. The company is publicly traded on the NASDAQ stock exchange under the ticker symbol VCYT.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!